NUL

👥 8 employees💰 Last funded Aug 2025
A proven, safe approach that can change everything. Nul’s alcohol reduction programme can change your relationship with alcohol, thanks to a NICE-approved, proven effective pill. Taken 1-2 hours before drinking, it blocks the endorphin receptors triggered by alcohol. Our programme is based on The Sinclair Method, which in studies helped 78% of people reduce or eliminate their alcohol consumption. After a simple online consultation, a clinician will, where suitable, prescribe a treatment plan. Our expert support, resources and tools will then guide you through your programme. We believe in sustainable and transformational change, so on top of the medication, we have created a bespoke IFS and polyvagal therapy programme to accompany the core programme. Allowing for a deeper dive into personal growth and healing to bring joy, ease and confidence to all aspects of daily life. ‍ By committing to Nul, you’ll be committing to finding more focus, more control, and more balance in every part of your life.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography2 countries
United Arab Emirates
1
United Kingdom
1
Frequently asked questions
Who invested in NUL?
NUL has 2 investors on record on gritt.io.
When did NUL last raise funding?
The most recent investment in NUL recorded on gritt.io was in August 2025.
What industry is NUL in?
NUL operates in Health and Human Services. Find similar Health and Human Services investors on gritt.io.